Moroni, F <br/><br/>
Kynurenine 3-mono-oxygenase inhibitors reduce glutamate concentration in the extracellular spaces of the basal ganglia but not in those of the cortex or hippocampus.  [electronic resource] 

 -  Neuropharmacology  May 2005 
 - 788-95 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0028-3908 
<br/><br/><label>Standard No.: </label>10.1016/j.neuropharm.2004.10.019  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Avoidance Learning--drug effects<br/>Basal Ganglia--drug effects<br/>Behavior, Animal--drug effects<br/>Brain Chemistry--drug effects<br/>Calcium Channel Blockers--pharmacology<br/>Chromatography, High Pressure Liquid--methods<br/>Dose-Response Relationship, Drug<br/>Drug Interactions<br/>Extracellular Space--drug effects<br/>Glutamic Acid--metabolism<br/>Kynurenic Acid--metabolism<br/>Kynurenine 3-Monooxygenase<br/>Male<br/>Microdialysis--methods<br/>Mixed Function Oxygenases--antagonists & inhibitors<br/>Potassium Chloride--pharmacology<br/>Rats<br/>Rats, Wistar<br/>Statistics, Nonparametric<br/>Sulfonamides--pharmacology<br/>Thiazoles--pharmacology<br/>Time Factors<br/>omega-Conotoxin GVIA--pharmacology